Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

416370

registered interest
date	04/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Wheelchairs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, with reference to Putting the wheels in motion: Assessing the value of British Red Cross short-term wheelchair loans, published by British Red Cross, July 2015, what assessment he has made of demand for short-term wheelchair loans.
tabling member constituency	North West Leicestershire
tabling member printed	Andrew Bridgen
uin	8538
answer	answer is ministerial correction date of answer 11/09/2015 answer text <p>Wheelchair services are the responsibility of local clinical commissioning groups (CCGs). No information is held centrally about the demand for short-term wheelchair loans, which are predominantly made by charities such as the Red Cross rather than by CCGs themselves.</p><p> </p><p><strong> </strong></p><p> </p><p>NHS England has recently established a new national wheelchair dataset, which went live from 1 July. This will enable the use of data in future to drive improvement in wheelchair services that are provided by the National Health Service.</p><p> </p> answering member constituency North East Bedfordshire answering member printed Alistair Burt question first answered 11/09/2015 11:12:43 answering member 1201 label Biography information for Alistair Burt
tabling member	4133 label Biography information for Andrew Bridgen

177182

registered interest
date	02/02/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Human Papillomavirus
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, with reference to paragraph 5.26 of his Department's report, An Intelligence Framework for Cancer published in December 2011, what discussions he has had with Public Health England on funding a new database to support the introduction of Primary HPV screening through a single national screening database.
tabling member constituency	North West Leicestershire
tabling member printed	Andrew Bridgen
uin	222866
answer	answer is ministerial correction date of answer 09/02/2015 answer text <p>Information technology to support cervical screening and the potential introduction of primary human papillomavirus (HPV) screening will be discussed at the next meeting of the Advisory Committee on Cervical Screening (ACCS) on 12 February 2015. Public Health England (PHE) will be made aware of any ACCS recommendations resulting from the meeting.</p><p> </p><p> </p><p> </p><p>In April 2014 the UK National Screening Committee gave its support for a pilot to assess the value of using HPV TaPS for cervical disease, rather than the currently used cytology test. The pilot is establishing the feasibility of using HPV testing as the primary screen for cervical disease in order to achieve better outcomes for women, while minimising over-treatment and anxiety, and whether it is practical to roll out nationally.</p><p> </p><p> </p><p> </p><p>The pilot programme was developed by PHE and advised by the Advisory Committee on Cervical Screening. The pilot sites, which began in May 2013, are: Liverpool, Manchester, Northwick Park (Harrow), Bristol, Sheffield and Norwich. The first evaluation report is due in spring 2015.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 09/02/2015 17:32:37 answering member 3918 label Biography information for Jane Ellison
tabling member	4133 label Biography information for Andrew Bridgen

156998

registered interest
date	20/11/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Drugs: Licensing
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, on what dates since 2 July 2014 he has discussed with charities the use of off-patent drugs for new indications; and what the content of these discussions was.
tabling member constituency	North West Leicestershire
tabling member printed	Andrew Bridgen
uin	215396
answer	answer is ministerial correction date of answer 27/11/2014 answer text <p>Off-patent drugs are those whose patent period has expired and they are widely used in the National Health Service now. Drugs can also be prescribed ‘off-label’ outside of their licensed indication(s) to individual patients where doctors consider it is clinically appropriate to do so. Prescribing decisions are rightly a matter for clinicians in discussion with their patients.</p><p> </p><p> </p><p> </p><p>My Rt. hon. Friend the Secretary of State has had no discussions with charities about the use of off-patent drugs for new indications since 2 July. Officials have had several discussions with the Breast Cancer Campaign covering their views on medicines licences, implementation of National Institute for Health and Care Excellence guidelines and planning the roundtable discussion on adoption of new evidence into clinical practice. There have also been ongoing discussions with Cancer Research UK on the use of aspirin to help prevent certain cancers.</p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 27/11/2014 17:23:49 answering member 4020 label Biography information for George Freeman
tabling member	4133 label Biography information for Andrew Bridgen

89707

registered interest
date	29/08/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of progress on the Cancer Strategy target of saving an additional 5,000 lives from cancer per year by 2014-15.
tabling member constituency	North West Leicestershire
tabling member printed	Andrew Bridgen
uin	207197
answer	answer is ministerial correction date of answer 05/09/2014 answer text <p> </p><p>Cancer survival and mortality rates continue to improve although it is too early to assess progress against our ambition to save an additional 5,000 lives per year by 2014-15, to halve the gap between the survival estimates in England and those in the best countries in Europe. Proxy measures are being developed to enable an assessment of progress in a more timely manner, particularly in terms of the proportion of cancers diagnosed at stages one and two and cancers diagnosed through emergency routes.</p><p> </p><p> </p><p> </p><p>The National Health Service and Public Health Outcomes Framework indicators and the Clinical Commissioning Group (CCG) Outcomes Indicator Set are starting to enable us to assess progress, at national and local level. For example, data on one-year survival from all cancers and one-year survival from breast, lung and colorectal cancer were published as part of the CCG outcomes indicator set for the first time on 19 June 2014. NHS England is continuing to monitor the progress of the NHS in reducing mortality from cancer in line with the NHS Outcomes Framework, and from 2014-15 there will be a range of new NHS Outcomes Framework indicators reflecting different stages of diagnosis which will provide a good proxy measure in future on progress in delivering earlier stage of diagnosis of cancer.</p><p> </p><p> </p><p> </p><p>The Mandate for the NHS for 2014-15 sets out an ambition for England to become one of the most successful countries in Europe at preventing premature deaths. Tackling premature deaths from cancer will contribute to this. A range of work at national and local level is aimed at improving cancer survival. For example, results from the first national “Be Clear on Cancer” lung cancer campaign in 2012 showed that around 700 extra patients were diagnosed with lung cancer compared to the previous year. Approximately 400 of these patients had their lung cancer diagnosed at an early stage, with around 300 more patients having surgery, giving them a better chance of survival.</p><p> </p><p> </p><p> </p><p>NHS England took over responsibility for the annual national cancer patient experience survey from April 2013. The survey results are used by a range of stakeholders to identify practices that lead to positive experience for patients, and promote improvements.</p><p> </p><p> </p><p> </p><p>NHS England is working with NHS Improving Quality and other partners to develop more effective ways of using the survey results within the NHS, for example, working with successful and struggling organisations to identify and spread best practice.</p><p> </p><p> </p><p> </p><p>CCGs are currently in the process of finalising measurable levels of ambition to improve patient experience and will be holding providers to account. These are based on NHS England's new measure for poor inpatient experience which includes whether patients are treated with dignity and respect.</p><p> </p><p> </p><p> </p><p>Compassion in Practice, the three year vision and strategy for nursing, midwifery and care staff, is also seeking to increase feedback from vulnerable and disadvantaged patient groups, who can have poorer experiences of care.</p><p> </p><p> </p><p> </p><p>In April 2014, NHS England introduced the staff friends and family test for all NHS Trusts in England, as research shows the strong link between levels of staff engagement and quality of patient experience.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 207199 question first answered 05/09/2014 13:25:58 answering member 3918 label Biography information for Jane Ellison
tabling member	4133 label Biography information for Andrew Bridgen

89722

registered interest
date	29/08/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Palliative Care
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, when the Palliative Care Funding Review pilots are due to report.
tabling member constituency	North West Leicestershire
tabling member printed	Andrew Bridgen
uin	207198
answer	answer is ministerial correction date of answer 05/09/2014 answer text <p>NHS England will publish a draft national tariff document in February 2015. This will include details of a development currency for palliative care which will be based upon the data collected as part of the Palliative Care Funding Review pilots and the views of the palliative care sector. A draft will be published as part of an engagement process in the autumn.</p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb question first answered 05/09/2014 09:46:02 answering member 1439 label Biography information for Norman Lamb
tabling member	4133 label Biography information for Andrew Bridgen

89723

registered interest
date	29/08/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps (a) his Department and (b) NHS England are taking to address weaknesses in cancer patient experience and staff engagement.
tabling member constituency	North West Leicestershire
tabling member printed	Andrew Bridgen
uin	207199
answer	answer is ministerial correction date of answer 05/09/2014 answer text <p> </p><p>Cancer survival and mortality rates continue to improve although it is too early to assess progress against our ambition to save an additional 5,000 lives per year by 2014-15, to halve the gap between the survival estimates in England and those in the best countries in Europe. Proxy measures are being developed to enable an assessment of progress in a more timely manner, particularly in terms of the proportion of cancers diagnosed at stages one and two and cancers diagnosed through emergency routes.</p><p> </p><p> </p><p> </p><p>The National Health Service and Public Health Outcomes Framework indicators and the Clinical Commissioning Group (CCG) Outcomes Indicator Set are starting to enable us to assess progress, at national and local level. For example, data on one-year survival from all cancers and one-year survival from breast, lung and colorectal cancer were published as part of the CCG outcomes indicator set for the first time on 19 June 2014. NHS England is continuing to monitor the progress of the NHS in reducing mortality from cancer in line with the NHS Outcomes Framework, and from 2014-15 there will be a range of new NHS Outcomes Framework indicators reflecting different stages of diagnosis which will provide a good proxy measure in future on progress in delivering earlier stage of diagnosis of cancer.</p><p> </p><p> </p><p> </p><p>The Mandate for the NHS for 2014-15 sets out an ambition for England to become one of the most successful countries in Europe at preventing premature deaths. Tackling premature deaths from cancer will contribute to this. A range of work at national and local level is aimed at improving cancer survival. For example, results from the first national “Be Clear on Cancer” lung cancer campaign in 2012 showed that around 700 extra patients were diagnosed with lung cancer compared to the previous year. Approximately 400 of these patients had their lung cancer diagnosed at an early stage, with around 300 more patients having surgery, giving them a better chance of survival.</p><p> </p><p> </p><p> </p><p>NHS England took over responsibility for the annual national cancer patient experience survey from April 2013. The survey results are used by a range of stakeholders to identify practices that lead to positive experience for patients, and promote improvements.</p><p> </p><p> </p><p> </p><p>NHS England is working with NHS Improving Quality and other partners to develop more effective ways of using the survey results within the NHS, for example, working with successful and struggling organisations to identify and spread best practice.</p><p> </p><p> </p><p> </p><p>CCGs are currently in the process of finalising measurable levels of ambition to improve patient experience and will be holding providers to account. These are based on NHS England's new measure for poor inpatient experience which includes whether patients are treated with dignity and respect.</p><p> </p><p> </p><p> </p><p>Compassion in Practice, the three year vision and strategy for nursing, midwifery and care staff, is also seeking to increase feedback from vulnerable and disadvantaged patient groups, who can have poorer experiences of care.</p><p> </p><p> </p><p> </p><p>In April 2014, NHS England introduced the staff friends and family test for all NHS Trusts in England, as research shows the strong link between levels of staff engagement and quality of patient experience.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 207197 question first answered 05/09/2014 13:25:58 answering member 3918 label Biography information for Jane Ellison
tabling member	4133 label Biography information for Andrew Bridgen

89725

registered interest
date	29/08/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	NHS: Training
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps his Department has taken to ensure that NHS staff can access training and development on providing care with dignity and respect.
tabling member constituency	North West Leicestershire
tabling member printed	Andrew Bridgen
uin	207200
answer	answer is ministerial correction date of answer 04/09/2014 answer text <p> </p><p>The Government has mandated Health Education England (HEE) to provide national leadership on education, training and workforce development in the National Health Service. HEE will work with healthcare stakeholders to influence training curricula as appropriate.</p><p> </p><p> </p><p> </p><p>Healthcare providers have a duty to invest in the training and education of new staff. Employers should support healthcare professionals to prioritise the quality of care, be compassionate, safety-conscious and genuinely listen to their patients.</p><p> </p><p> </p><p> </p><p>Local Education Training Boards provide the forum for securing the development of the whole health workforce and have a role in ensuring employers remain committed to continuing professional development.</p><p> </p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter question first answered 04/09/2014 13:35:30 answering member 3932 label Biography information for Dr Dan Poulter
tabling member	4133 label Biography information for Andrew Bridgen

79245

registered interest
date	22/07/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Palliative Care
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps his Department is taking to improve the support that people at the end of life receive so that they can die in their preferred place of care.
tabling member constituency	North West Leicestershire
tabling member printed	Andrew Bridgen
uin	206833
answer	answer is ministerial correction date of answer 02/09/2014 answer text <p> </p><p>The Government is committed to expanding choice in end of life care by supporting people’s preferences about how to have a good death. On 1 July 2014, we announced a review of choice in end-of-life care led by Claire Henry, Chief Executive of the National Council for Palliative Care.</p><p> </p><p> </p><p> </p><p>The Programme Board leading this work consists of representatives from charities, people with personal experience of end of life care (including carers), clinicians and policy makers. The review will undertake extensive public consultation to define what people want in end of life services, and will provide advice to the Government on the policy initiatives required to enable people’s preferences to be met. This advice will be provided by early next year.</p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb question first answered 02/09/2014 14:39:58 answering member 1439 label Biography information for Norman Lamb
tabling member	4133 label Biography information for Andrew Bridgen

62920

registered interest
date	19/06/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Breast Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how clinical commissioning groups are held to account for the performance of services against each of the 13 statements of the National Institute for Health and Care Excellence breast cancer quality standard.
tabling member constituency	North West Leicestershire
tabling member printed	Andrew Bridgen
uin	201409
answer	answer is ministerial correction date of answer 26/06/2014 answer text <p>The majority of treatments for cancer such as radiotherapy and chemotherapy (for all cancers), and services for rarer cancers are commissioned nationally by NHS England. Commissioning is informed by a range of clinical reference groups established as a primary source of advice on best practice, service standards for commissioned providers, and forward strategy and innovation.</p><p> </p><p>National Institute for Health and Care Excellence (NICE) quality standards define clinical best practice for the diagnosis and treatment of breast cancer to help clinicians ensure that patients are given information about the treatment options available and help in choosing the best option to suit them.</p><p> </p><p>The Health and Social Care Act (2012) places a duty on NHS England to have regard to NICE quality standards. NHS England would expect clinical commissioning groups (CCGs) to take into account NICE quality standards when commissioning breast cancer services.</p><p> </p><p>No assessment has been made of the performance of services against the breast cancer quality standard. However, compliance with quality standards generally could be monitored through a range of mechanisms depending on the specific quality standard, for example, the 30 national clinical audits funded by NHS England, the Best Practice Tariff, Commissioning for Quality Improvement Initiatives arrangements and the CCG Outcome Indicator Set. These levers are designed to drive quality improvement in the National Health Service using quality standards where appropriate. NHS England's National Clinical Directors actively promote existing NICE quality standards.</p><p> </p><p>At the request of NHS England, the Healthcare Quality Improvement Partnership will shortly begin commissioning a new national breast cancer clinical audit. There is an expectation that national clinical audits, where appropriate, support the implementation of NICE clinical guidelines and quality standards. The new national clinical audit will be in place by the end of 2014-15.</p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 201405 question first answered 26/06/2014 14:34:50 answering member 3918 label Biography information for Jane Ellison
tabling member	4133 label Biography information for Andrew Bridgen

62922

registered interest
date	19/06/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Public Health England
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many full-time equivalent staff Public Health England employed to work on cancer policy at a national level in each of the last two financial years.
tabling member constituency	North West Leicestershire
tabling member printed	Andrew Bridgen
uin	201403
answer	answer is ministerial correction date of answer 26/06/2014 answer text <p>Public Health England is not responsible for policy on cancer, but does ensure the delivery of several cancer related functions including NHS Cancer Screening Programmes, Be Clear on Cancer campaigns, cancer screening quality assurance, the National Cancer Intelligence Network and the National Cancer Registration Service. National strategic oversight and policy on cancer screening, early diagnosis and cancer informatics remains with the Department with 3.5 whole time equivalent posts.</p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 201406 question first answered 26/06/2014 14:12:28 answering member 3918 label Biography information for Jane Ellison
tabling member	4133 label Biography information for Andrew Bridgen